Skip to main content
. 2010 Sep 10;299(5):H1374–H1381. doi: 10.1152/ajpheart.00168.2010

Table 2.

LV hemodynamics 10 days after Dox injection in WT and CrmA Tg mice

Vehicle Dox Dox + 4-AN
LVEDP, mmHg
    WT 3.5 ± 1.1 7.1 ± 0.8* 4.2 ± 0.5
    CrmA 3.1 ± 0.3 7.1 ± 0.6* 3.3 ± 0.5
LVSP, mmHg
    WT 107.9 ± 2.2 91.24 ± 5.7* 103.4 ± 3.8
    CrmA 111.8 ± 3.2 82.3 ± 2.6* 105.2 ± 6.6
dP/dtmax, mmHg/s
    WT 8,693 ± 304 6,529 ± 715* 8,102 ± 461
    CrmA 8,896 ± 486 5,816 ± 1075* 8,413 ± 265
dP/dtmin, mmHg/s
    WT 7,282 ± 530 4,202 ± 480* 6,914 ± 246
    CrmA 6,945 ± 562 3,029 ± 548* 6,026 ± 359
CO, ml/min
    WT 5.0 ± 0.4 2.8 ± 0.2* 4.8 ± 0.4
    CrmA 5.2 ± 0.5 2.3 ± 0.1* 4.4 ± 0.6
τ, ms
    WT 12.4 ± 1.1 23.0 ± 4.0* 13.6 ± 1.2
    CrmA 11.5 ± 0.7 24.8 ± 2.3* 14.0 ± 1.2

Values are means ± SE; n = 6 to 7 mice. τ, ventricular isovolumic relaxation time constant.

*

P < 0.05, Dox vs. vehicle;

P < 0.05, Dox vs. Dox + 4-amino-1,8-naphthalimide (4-AN).